INTRODUCTION
Abortion is defined as termination of pregnancy before the period of viability, which occurs at 20 weeks of gestation and the foetus weighing 500 g. About 40-60 million abortions occur per year globally. Medical abortion is a safe alternative to surgical methods. MTP was legalized in India in 1971. 1 Estimate indicate that 46 million pregnancies are voluntarily terminated each year, 26 million legally and 20 million outside the legal system. 2 Various management protocols have been used for second trimester pregnancy termination. These includes surgical techniques (D&E) and medical approaches such as intra-amniotic prostaglandin (PG) F 2 -α instillation, PGE 2 vaginal suppositories, PGE 2 and high-dose oxytocin. 3 All these methods require hospitalization and have disadvantage of surgical trauma and anaesthetic complication. PGE 1 analogue, misoprostol, originally used for the treatment of peptic ulcer, has been found to have uterotonic effect as well and is used for termination of pregnancy for great success. Chemical formula of misoprostol is C 22 H 38 O 5 or (±) -methyl (13E)-11, 16-dihydroxy-16 methyl-9-oxo-prost-13-eonate. Misoprostol is available as 100 and 200 µg tablets and can be used orally, vaginally and rectally. It is cheap, stable at room temperature, does not need refrigeration and is associated with few side effects. [4] [5] Associate Professor, Department of Obstetrics and Gynaecology, Chhattisgarh Institute of Medical Sciences, Bilaspur-495001, Chhattisgarh, India
In Group A, induction was carried out on inpatient basis by giving 400 µg sublingually, there after 200 µg sublingually 3 hourly till abortion. In Group B, induction was carried out on inpatient basis by inserting 400 µg misoprostol tablets into posterior fornix, keeping the patient strictly in bed for half an hour. There after 200 µg tablets were inserted intravaginally every 3 hourly until abortion. Time of onset of contraction, bleeding, pain, cervical dilatation, expulsion of fetes including placenta and membrane were looked for. All vital parameters were closely monitored and side effects if any were symptomatically managed. They were kept under observations for two hours after abortion. Patients were discharged with the advice to come for follow-up after two weeks or earlier if necessary. The data was entered and analyzed through software program SPSS (Statistical Package for the Social Sciences) for statistical analysis. The results were represented as mean and standard deviation. The mean induction abortion interval and mean dose required were analyzed by standard error of difference between two means. Success rate and side effects due to different routes of administration were analyzed by their percentage and compared by chi-square test.
RESULTS
Majority of our patients were married, of 20-30 years of age (Table 1) . Forty-nine (98%) women aborted within 24 hours in sublingual misoprostol group as compared to 47 (94%) in vaginal group. In majority of women pain started within two hours (mean 3.5 ± 2.33) in sublingual misoprostol group as compared to (mean3.9 ± 2.46) the vaginal group. Vaginal bleeding started within 4-6 hours (mean 5.26 ± 2.9) in the sublingual misoprostol group as compared to (mean 6.29 ± 2.33) the vaginal group. *Difference between the two mean is 3.9. I.e. more than three times the SE which is highly significant? Table 3 : Gestational age, induction-abortion interval and mean dose of misoprostol.
*Difference between the two mean is 4.8 i.e. more than 3 times of SE and is highly significant Abortion was considered to be successful, if there was expulsion of fetus with or without expulsion of placenta occurring within 24 hours of insertion of first dose. Success rate was 98% for sublingual group and 94%for vaginal group. A significant observation was that all women in the sublingual group aborted within 24 hours while only 89% in the vaginal group aborted in 24 hours.
There was no difference in success rate with reference to parity and gestational age in both the groups.
Abortion was said to be incomplete, if either whole of placenta or part of it was retained for more than three hours after expulsion of fetus or if excessive bleeding started and required evacuation. Abortion was complete in 87.8% and 81% of case in sublingual and vaginal group, respectively. This difference was not statistically significant indicating that misoprostol administered through any route is equally effective but there was a definite reduction in induction-abortion interval on sublingual administration. The various side effects observed were nausea, vomiting, pyrexia (p < 0.05), abdominal cramps and fatigue (Table 4) . Sublingual route was the most acceptable, subjective assessment of patient comfort to the route of administration was high in sublingual group (90%) and 60% in Vaginal group. Sublingual route was convenient to administer, had less side effects, required short hospital stay.
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DISCUSSION
Medical abortion is becoming more popular now days as a method of termination of pregnancy in second trimester because it is effective and technically less demanding when compared to surgical methods. 1 Prostaglandin analogs are the mainstay of drugs used for this purpose. Among them, misoprostol is the most commonly used one, as it is cheap and stable at room temperature. It has been shown to be effective for second trimester termination of pregnancy. 2 Misoprostol has been used to induce medical abortion by various routes of administration. Vaginal misoprostol has been shown to be more effective than oral misoprostol. However, evidence that absorption through the vaginal route is inconsistent and that the patients find vaginal administration uncomfortable has led to the sublingual route as an alternative. Oral misoprostol reaches a high peak concentration in blood very quickly before a rapid fall in plasma level. After vaginal administration there is gradual rise up to peak level and then a slow fall of level. [3] [4] [5] [6] [7] Earlier studies by various authors 2-7 comparing oral with vaginal administration with the dose regimes varying from 400-800 µg at 3-hourly to 8-hourly interval have reported the success rate on vaginal administration to be in range of 56.8-99.26%.The induction-abortion interval observed was shorter than that observed in the other studies using misoprostol by various routes or by combination of routes for second trimester termination of pregnancy (Table VI) .
Recently, it has been shown that misoprostol can be administered sublingually. A pharmacokinetic study has shown that after a single dose of sublingual misoprostol, the peak concentration is achieved in a shorter time than with vaginal misoprostol. The peak concentration and bioavailability were also higher with sublingual administration. Therefore, it was postulated that sublingual route of administration might be the most effective route for administration of misoprostol by Tang et al. 5 A study by Tang et al 8 of 18 cases administered misoprostol 200 ug. administered 3-hourly sublingually demonstrated 100% success rate with a mean induction abortion interval (12 ± 3.6 hours). In the same author study, sublingual misoprostol in gestational age <12 weeks reported success rate of about 86%. 9 Helena et al 11 demonstrated that repeated administration of 400 µg Misoprostol either vaginally or sublingually is an effective and acceptable option. However vaginal administration appears to produce better results among multiparous women, but more women had fever >38C in Vaginal route. Shah et al 12 studied role of vaginal Misoprostol for second trimester termination. They found it is effective and time saving drug for second trimester abortion. 96.6% women aborted within 20 hours. Mean Induction abortion interval was 9.43 hours with very low drug related side effects. Milani et al 13 reported similar results as in our study. Dickson et al 14 studied Oral, Vaginal and sublingual Misoprostol for second trimester abortion. They found that Vaginal or sublingual Misoprostol administrated after vaginal loading dose in second trimester abortion with Mifepristone is associated with a shorter time to pregnancy termination compared with an oral regime. Using a high loading dose initially followed by low-dose at proper intervals to maintain sustained effect brings about effective uterine contraction and shorter inductionabortion interval. In our study, we used an initial high dose of 400 µg sublingually followed by 200 µg 3 hourly in Group A and 400 µg intravaginally followed by 200 µg 3 hourly in Group B. In our study, we compared sublingual land vaginal route of administration of misoprostol and sublingual route of administration have a short induction abortion interval, better success rate and less side effects which were statistically significant as compared to vaginal route of administration. Side effects observed were minor in nature and required symptomatic management only.
Sublingual misoprostol has the advantage that it can avoid the uncomfortable and inconvenient vaginal administration. This is especially true if women start to bleed, when the absorption of the drug may be affected.
Although other studies 1, 7, 14 have advised against carrying out caesarean myomectomy in patients with multiple fibroids, fundal intramural fibroids in the vicinity of the tubes, and patients with dense pelvic adhesions; we would clarify that the danger in multiple fibroid is significant if there are >10 fibroids. We also avoided caesarean myomectomy in patients with big broad ligament fibroids. The impact of this study however, maybe limited by our small sample size (n=64). Further research with larger sample size could help explore our findings.
CONCLUSIONS
Misoprostol administered alone either sublingually or vaginally is an efficient drug for second trimester medical termination of pregnancy. Sublingual route is better because of its high acceptability, short induction abortion interval, more efficacies with more comfort on route of administration and lesser side effects.
